Our study demonstrates that treatment of melanoma cells with cryptolepine resulted in reduced levels of SDH-A protein (a nuclear genome-encoded protein which is a component of Complex II enzyme) as well as COX-I protein (a mitochondrial genome-encoded protein, which is a subunit of the COX-IV enzyme complex). This evidence concerns the gene SDHA and melanoma.